Pages that link to "Q45938423"
Jump to navigation
Jump to search
The following pages link to Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. (Q45938423):
Displaying 50 items.
- Optimizing Outcomes in Immunocompromised Hosts: Understanding the Role of Immunotherapy in Invasive Fungal Diseases (Q26774692) (← links)
- Adoptive T-cell therapy for fungal infections in haematology patients (Q26781064) (← links)
- β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3) (Q26825753) (← links)
- Pneumonia in the neutropenic cancer patient (Q26827758) (← links)
- Antifungal Therapy in Hematopoietic Stem Cell Transplant Recipients (Q28080147) (← links)
- Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients (Q28083874) (← links)
- The temporal dynamics of differential gene expression in Aspergillus fumigatus interacting with human immature dendritic cells in vitro (Q28476745) (← links)
- Gymnemic acids inhibit hyphal growth and virulence in Candida albicans (Q28533240) (← links)
- Biology, systematics, and clinical manifestations of Zygomycota infections (Q28656453) (← links)
- Clinical characteristics and outcomes in 303 HIV-infected patients with invasive fungal infections: data from the Prospective Antifungal Therapy Alliance registry, a multicenter, observational study (Q30781344) (← links)
- Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data. (Q30829283) (← links)
- Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study. (Q30840066) (← links)
- Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™. (Q31037255) (← links)
- Trends in Hospitalizations Related to Invasive Aspergillosis and Mucormycosis in the United States, 2000-2013. (Q33629045) (← links)
- Infections in Hematopoietic Cell Transplant Recipients: Results From the Organ Transplant Infection Project, a Multicenter, Prospective, Cohort Study (Q33641898) (← links)
- Invasive fungal infections in transplant recipients (Q33695215) (← links)
- Cryptococcosis in patients with hematological diseases: a 14-year retrospective clinical analysis in a Chinese tertiary hospital (Q33868567) (← links)
- Influence of Polymorphisms in Innate Immunity Genes on Susceptibility to Invasive Aspergillosis after Stem Cell Transplantation (Q33869448) (← links)
- Fungal infections in transplant and oncology patients (Q33896940) (← links)
- Hydrophobicity and helicity regulate the antifungal activity of 14-helical β-peptides (Q33926906) (← links)
- In vitro antifungal activities of bis(alkylpyridinium)alkane compounds against pathogenic yeasts and molds (Q34045255) (← links)
- Epidemiology and antifungal susceptibility of bloodstream fungal isolates in pediatric patients: a Spanish multicenter prospective survey (Q34051921) (← links)
- Molecular and nonmolecular diagnostic methods for invasive fungal infections (Q34057660) (← links)
- In vitro protease inhibition and cytotoxicity of Aspergillus fumigatus biomolecules secreted under long-term aerated conditions (Q34102048) (← links)
- International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole. (Q34151084) (← links)
- Recent Advances in the Treatment of Mucormycosis (Q34161213) (← links)
- Resistance to antifungals that target CYP51. (Q34276700) (← links)
- Breakthrough Hormographiella aspergillata infections arising in neutropenic patients treated empirically with caspofungin (Q34487440) (← links)
- Weekly use of fluconazole as prophylaxis in haematological patients at risk for invasive candidiasis (Q34517297) (← links)
- Decreased mental health care utilization following a psychosocial intervention in caregivers of hematopoietic stem cell transplant patients (Q34619092) (← links)
- Evaluation of MycAssay™ Aspergillus for diagnosis of invasive pulmonary aspergillosis in patients without hematological cancer (Q34688953) (← links)
- Secondary antifungal prophylaxis in hematological malignancy patients with previous invasive fungal disease: a retrospective analysis (Q34756973) (← links)
- The Y238X stop codon polymorphism in the human β-glucan receptor dectin-1 and susceptibility to invasive aspergillosis (Q34772679) (← links)
- Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach (Q34932560) (← links)
- A breath fungal secondary metabolite signature to diagnose invasive aspergillosis (Q35029333) (← links)
- Epidemiology and treatment approaches in management of invasive fungal infections (Q35089772) (← links)
- Divergent targets of Aspergillus fumigatus AcuK and AcuM transcription factors during growth in vitro versus invasive disease (Q35098167) (← links)
- Comparison of in vitro susceptibility characteristics of Candida species from cases of invasive candidiasis in solid organ and stem cell transplant recipients: Transplant-Associated Infections Surveillance Network (TRANSNET), 2001 to 2006 (Q35140151) (← links)
- Emerging fungal infections in immunocompromised patients (Q35161571) (← links)
- Gene expression profiles of human dendritic cells interacting with Aspergillus fumigatus in a bilayer model of the alveolar epithelium/endothelium interface (Q35175339) (← links)
- Causes of death in a contemporary cohort of patients with invasive aspergillosis (Q35213770) (← links)
- Safety of voriconazole and sirolimus coadministration after allogeneic hematopoietic SCT. (Q35231368) (← links)
- Rapid screening for human-pathogenic Mucorales using rolling circle amplification. (Q35237942) (← links)
- Clinical challenge: fatal mucormycotic osteomyelitis caused by Rhizopus microsporus despite aggressive multimodal treatment. (Q35241064) (← links)
- Impaired T cell responsiveness to interleukin-6 in hematological patients with invasive aspergillosis (Q35250694) (← links)
- Validation of a new Aspergillus real-time PCR assay for direct detection of Aspergillus and azole resistance of Aspergillus fumigatus on bronchoalveolar lavage fluid (Q35331642) (← links)
- Efficacy and safety of echinocandins versus triazoles for the prophylaxis and treatment of fungal infections: a meta-analysis of RCTs (Q35515892) (← links)
- Invasive aspergillosis in patients with hematologic malignancies: incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009. (Q35528678) (← links)
- Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation (Q35659502) (← links)
- Differences in efficacy and cytokine profiles following echinocandin or liposomal amphotericin B monotherapy or combination therapy for murine pulmonary or systemic Aspergillus flavus infections (Q35666612) (← links)